Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Veraxa Biotech AG - Warrants (08/06/2031)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Veraxa Biotech AG - Warrants (08/06/2031) 52 week high is $0.35 as of June 17, 2026.
What is the 52-week low for Veraxa Biotech AG - Warrants (08/06/2031)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Veraxa Biotech AG - Warrants (08/06/2031) 52 week low is $0.17 as of June 17, 2026.
What is Veraxa Biotech AG - Warrants (08/06/2031) stock price today?
Veraxa Biotech AG - Warrants (08/06/2031) stock price today is $0.1801.
What was Veraxa Biotech AG - Warrants (08/06/2031) stock price yesterday?
Veraxa Biotech AG - Warrants (08/06/2031) stock price yesterday was $0.2863.
What is the 50-day moving average of Veraxa Biotech AG - Warrants (08/06/2031)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Veraxa Biotech AG - Warrants (08/06/2031) 50-day moving average is $0.2439.